Both in Pharmaceuticals
Spruce Biosciences vs Cue Biopharma
Over the past year SPRB returned −58.6% and CUE returned −7.4%; their daily moves had a correlation of 0.07.
SPRB −58.6% CUE −7.4%Growth of $1, one year, split-adjusted
| Metric | SPRB | CUE |
|---|---|---|
| Price | $43.38 | $19.94 |
| Market cap | $124.7M | $144.9M |
| Today | −2.63% | +2.68% |
| 1 month | −4.5% | −18.1% |
| 6 months | −26.9% | −42.9% |
| Year to date | −50.2% | +117.6% |
| 1 year | −60.6% | −13.4% |
| Revenue growth (YoY) | — | +166.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −1943.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.8× |
| Net cash | $89.2M | $16.4M |
| Dividend yield | — | — |
| Volatility (60d) | 64.2% | 137.7% |
| Short % of float | 22.4% | 12.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).